Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Rank Network Comparison Type red Gene green Filtered network_comparison
Results: HTML CSV LaTeX
Showing element 1851 to 1900 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear autoantigen sp-100 (speckled 100 kda) (nuclear dot-associated sp100 protein) (lysp100b). [source:swissprot;acc:p23497]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3184\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
34190.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
40795.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19318\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor (erythroid-derived 2)-like 3; nf-e2-related factor 3. [source:refseq;acc:nm\_004289]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1664\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7433.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7950.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06953\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor erythroid 2 related factor 1 (nf-e2 related factor 1) (nfe2-related factor 1) (nuclear factor, erythroid derived 2, like 1) (transcription factor 11) (transcription factor hbz17) (transcription factor lcr-f1) (locus control region-factor 1). [source:swissprot;acc:q14494]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1663\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p100/p49 subunits (h2tf1) (oncogene lyt-10) (lyt10) [contains: nuclear factor nf-kappa-b p52 subunit]. [source:swissprot;acc:q00653]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2661\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.26\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00821\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p105 subunit (dna-binding factor kbf1) (ebp- 1) [contains: nuclear factor nf-kappa-b p50 subunit]. [source:swissprot;acc:p19838]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2659\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.29\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor related to kappa b binding protein. [source:refseq;acc:nm\_006165]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2823\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear factor, interleukin 3 regulated. [source:refseq;acc:nm\_005384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1232\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5869.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6367.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear fragile x mental retardation protein interacting protein 1; nuclear fragile x mental retardation intercating protein 1; nuclear fragile x mental retardation protein-interacting protein 1. [source:refseq;acc:nm\_012345]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
534\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4651.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5296.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13863\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear hormone receptor nor-1 (neuron-derived orphan receptor 1) (mitogen induced nuclear orphan receptor). [source:swissprot;acc:q92570]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1282\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6744.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08249\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
333\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5039.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18299\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear pore complex protein nup214 (nucleoporin nup214) (214 kda nucleoporin) (can protein). [source:swissprot;acc:p35658]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3008\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear pore complex protein nup88 (nucleoporin nup88) (88 kda nuclear pore complex protein). [source:swissprot;acc:q99567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
879\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5797.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6391.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear pore complex protein nup98 (nucleoporin nup98) (98 kda nucleoporin). [source:swissprot;acc:p52948]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1061\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5412.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5913.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
397\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5367.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6233.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear protein ukp68. [source:refseq;acc:nm\_024824]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
106\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4241.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5810.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.36996\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear receptor co-repressor/hdac3 complex subunit tblr1 (tbl1- related protein 1). [source:swissprot;acc:q9bzk7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
796\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [source:refseq;acc:nm\_181782]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2144\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5859.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6173.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05369\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
423\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15423\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
422\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5206.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
608\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4510.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5098.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13039\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
136\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclear transport factor 2 (ntf-2) (placental protein 15) (pp15). [source:swissprot;acc:p13662]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3113\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nuclease sensitive element binding protein 1 (y box binding protein-1) (y-box transcription factor) (yb-1) (ccaat-binding transcription factor i subunit a) (cbf-a) (enhancer factor i subunit a) (efi-a) (dna-binding protein b) (dbpb). [source:swissprot;acc:p16991]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2094\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6682.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7051.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05522\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleobindin 1 precursor (calnuc). [source:swissprot;acc:q02818]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
937\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5859.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6432.03\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09776\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nucleobindin 2 precursor (dna-binding protein nefa). [source:swissprot;acc:p80303]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
939\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
428\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3721.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4288.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15237\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar phosphoprotein p130 (nucleolar 130 kda protein) (140 kda nucleolar phosphoprotein) (nopp140) (nucleolar and coiled-body phosphoprotein 1). [source:swissprot;acc:q14978]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2842\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
213\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4446.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5553.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24896\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
997\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5144.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5634\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0951\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1121\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4338.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4725.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08929\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar protein nop56 (nucleolar protein 5a). [source:swissprot;acc:o00567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
619\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3879.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4371.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12661\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolar rna-associated protein alpha isoform. [source:refseq;acc:nm\_022917]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
755\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4079.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4545.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolysin tia-1 (rna-binding protein tia-1) (p40-tia-1) [contains: p15-tia-1]. [source:swissprot;acc:p31483]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
80\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4133.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5945.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.43834\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleolysin tiar (tia-1 related protein). [source:swissprot;acc:q01085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
81\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4136.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5943.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.43691\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleophosmin (npm) (nucleolar phosphoprotein b23) (numatrin) (nucleolar protein no38). [source:swissprot;acc:p06748]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2785\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoplasmin 3. [source:swissprot;acc:o75607]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3096\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoporin 50 kda (nuclear pore-associated protein 60 kda-like) (pro1146). [source:swissprot;acc:q9ukx7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3154\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1999\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5047.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5344.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05894\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1993\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6174.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6538.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05895\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2430\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7243.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7509.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoporin-like protein rip (hiv-1 rev-binding protein) (rev interacting protein) (rev/rex activation domain-binding protein). [source:swissprot;acc:p52594]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2557\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5291.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5187.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02002\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoside diphosphate kinase 3 (ec 2.7.4.6) (ndk 3) (ndp kinase 3) (nm23-h3) (dr-nm23). [source:swissprot;acc:q13232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
618\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7878.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8879.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoside diphosphate kinase a (ec 2.7.4.6) (ndk a) (ndp kinase a) (tumor metastatic process-associated protein) (metastasis inhibition factor nm23) (nm23-h1). [source:swissprot;acc:p15531]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
638\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7755.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8730.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12572\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleoside diphosphate kinase b (ec 2.7.4.6) (ndk b) (ndp kinase b) (nm23-h2) (c-myc purine-binding transcription factor puf). [source:swissprot;acc:p22392]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
639\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7753.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8728.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 1 (nap-1 related protein). [source:swissprot;acc:p55209]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2757\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 2 (brain-specific protein, x- linked). [source:swissprot;acc:q9ulw6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2758\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 4 (nucleosome assembly protein 2) (nap2). [source:swissprot;acc:q99733]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3080\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/